COVID-19 Epidemiology in Rheumatic Diseases in Tuscany: A Case-control Study
Overview
Authors
Affiliations
Clinical outcomes of COVID-19 in patients with chronic diseases.
Sertbas Y, Solak E, Dagci S, Kizilay V, Yazici Z, Elarslan S North Clin Istanb. 2023; 10(4):401-410.
PMID: 37719255 PMC: 10500237. DOI: 10.14744/nci.2022.64436.
Mathew J, Jain S, Susngi T, Naidu S, Dhir V, Sharma A Rheumatol Adv Pract. 2023; 7(1):rkad025.
PMID: 36908302 PMC: 9995091. DOI: 10.1093/rap/rkad025.
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.
Grainger R, Kim A, Conway R, Yazdany J, Robinson P Nat Rev Rheumatol. 2022; 18(4):191-204.
PMID: 35217850 PMC: 8874732. DOI: 10.1038/s41584-022-00755-x.
Conway R, Grimshaw A, Konig M, Putman M, Duarte-Garcia A, Tseng L Arthritis Rheumatol. 2021; 74(5):766-775.
PMID: 34807517 PMC: 9011807. DOI: 10.1002/art.42030.
SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.
Ko T, Dendle C, Woolley I, Morand E, Antony A Hum Vaccin Immunother. 2021; 17(11):4048-4056.
PMID: 34357827 PMC: 8828082. DOI: 10.1080/21645515.2021.1958611.